Lisa Walters-Hoffert - 19 Aug 2024 Form 4 Insider Report for KIORA PHARMACEUTICALS INC (KPRX)

Reporting relationship: Director
Issuer ticker: KPRX
Reported as of: 19 Aug 2024
Net transaction value: +$4,825
SEC form: 4
Accepted by SEC: 20 Aug 2024, 13:00:12 UTC
Prior SEC filing: 03 Jul 2024
Next SEC filing: 02 Apr 2025
Source filing: View source filing
Reporting owner signature: /s/ Melissa Tosca, Attorney-in-Fact

Key filing fact

Lisa Walters-Hoffert filed Form 4 for KIORA PHARMACEUTICALS INC (KPRX) on 20 Aug 2024.

Key facts

This page summarizes Lisa Walters-Hoffert's Form 4 filing for KIORA PHARMACEUTICALS INC (KPRX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 20 Aug 2024, 13:00.

Change

Previous filing in this sequence was filed on 03 Jul 2024.
Current net transaction value: +$4,825.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KPRX transaction

Common Stock

Purchase

Transaction value: $4,825
Shares: +1,250
Change %
Price: $3.86
Shares after: 1,250
Date: 19 Aug 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares were purchased in multiple transactions at prices ranging from $3.815 to $3.8798. The reported price of $3.86 represents the volume weighted average price for the reported transaction. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.